Inhibitor Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Inhibitor Therapeutics, Inc. (INTI) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $6.56 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-26
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.56K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.99K.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8.41K.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9.96K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $6.56K 10-K · filed 2026-03-26 |
| 2025-09-30 | $6.99K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $8.41K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $9.96K 10-Q · filed 2025-05-14 |